EMGALITY 100 MG/ML SOL INJ CT 3 SER PREENC VD TRANS X 1 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1003302240071 -
GGREM
523724020051917 -
Código de barras
7896094211711
O que a fonte publica
- Detentor do registro
- LIBBS FARMACÊUTICA LTDA
- Princípios ativos
- GALCANEZUMABE
- Embalagem
- 100 MG/ML SOL INJ CT 3 SER PREENC VD TRANS X 1 ML
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- N2C2 - ANTAGONISTAS DA CGRP ANTI-ENXAQUECA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "EMGALITY 100 MG/ML SOL INJ CT 3 SER PREENC VD TRANS X 1 ML",
"holder": "LIBBS FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896094211711"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "523724020051917",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.230.314/0001-75",
"priceRegime": "Regulado",
"productName": "EMGALITY",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "100 MG/ML SOL INJ CT 3 SER PREENC VD TRANS X 1 ML",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "5750.73",
"icms-12": "6534.92",
"icms-17": "6928.59",
"icms-18": "7013.08",
"icms-19": "7099.67",
"icms-20": "7188.41",
"icms-21": "7279.41",
"icms-22": "7372.73",
"icms-23": "7468.48",
"icms-17.5": "6970.58",
"icms-19.5": "7143.76",
"icms-20.5": "7233.62",
"icms-22.5": "7420.30",
"icms-12-alc": "5834.75",
"icms-17-alc": "6186.24",
"icms-18-alc": "6261.68",
"icms-19-alc": "6338.98",
"icms-20-alc": "6418.22",
"icms-21-alc": "6499.47",
"icms-22-alc": "6582.79",
"icms-23-alc": "6668.28",
"withoutTaxes": "5134.58",
"icms-17.5-alc": "6223.73",
"icms-19.5-alc": "6378.36",
"icms-20.5-alc": "6458.59",
"icms-22.5-alc": "6625.26"
},
"pisCofinsList": "Negativa",
"substanceText": "GALCANEZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "7714.40",
"icms-12": "8766.36",
"icms-17": "9294.46",
"icms-18": "9407.80",
"icms-19": "9523.95",
"icms-20": "9643.00",
"icms-21": "9765.07",
"icms-22": "9890.25",
"icms-23": "10018.70",
"icms-17.5": "9350.78",
"icms-19.5": "9583.10",
"icms-20.5": "9703.64",
"icms-22.5": "9954.07",
"icms-12-alc": "8066.20",
"icms-17-alc": "8552.11",
"icms-18-alc": "8656.41",
"icms-19-alc": "8763.27",
"icms-20-alc": "8872.81",
"icms-21-alc": "8985.14",
"icms-22-alc": "9100.32",
"icms-23-alc": "9218.51",
"withoutTaxes": "7098.25",
"icms-17.5-alc": "8603.94",
"icms-19.5-alc": "8817.71",
"icms-20.5-alc": "8928.62",
"icms-22.5-alc": "9159.03"
},
"invalidBarcodes": [],
"activeSubstances": [
"GALCANEZUMABE"
],
"therapeuticClass": "N2C2 - ANTAGONISTAS DA CGRP ANTI-ENXAQUECA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1003302240071",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N2C2",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:523724020051917"